The cruise company is doing an audit on all of its cruise lines' safety measures following the Costa Concordia crash in January."We continue to believe that the adverse effects on demand caused by the Costa Concordia incident will be relatively short lived and that investors should focus on the medium term strengths of the business," Jefferies analysts wrote in a Feb. 7 report. "Capacity additions remain subdued and underlying demand is firm, buoyed by decent US GDP growth and falling unemployment in key markets such as the US and Germany." Forward Annual Dividend Yield: 3.3% Rated "B- (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin dropped from the previous year. Carnival has very weak liquidity. Its Quick Ratio is 0.12, which demonstrates a lack of ability to meet its short-term cash needs. In the fourth quarter, stockholders' net worth has increased 3.47% from the prior year. TheStreet Ratings' price target is $36.93. The stock closed Friday at $30.97 and has declined 5.12% year to date.
Allergan The health care company reported earlier this month earnings of $279.8 million, or 92 cents a share, up from year-ago earnings of $263.1 million, or 87 cents. "Management sounded confident in the potential for its current products and pipeline to drive strong growth," Bank of America Merrill Lynch analysts wrote in a Feb. 9 report. "Re-loading the pipeline through both internal and external efforts (supported by strong cash flow) will be a priority for 2012. We are maintaining our Buy rating, as we believe that AGN's diversified revenue base, strong pipeline, focus on innovation, and productive R&D engine position the company well for continued strong and sustainable revenue and EPS growth." Forward Annual Dividend Yield: 0.2% Rated "A- (Buy)" by TheStreet Ratings: The company's fourth-quarter gross profit margin was basically the same as the prior year. Allergan is extremely liquid. Its Quick Ratio is 3.47, which shows the company can meet its short-term cash needs. In the fourth quarter, stockholders' net worth increased 11.60% from the prior year. TheStreet Ratings' price target is $109.39. The stock closed Friday at $87.91 and has risen slightly year to date.